SPR 2018 Oncologic Imaging Course

Friday, November 9, 2018

Liver Tumors - SAM Session
Moderator: Beth McCarville, MD

8:00 - 8:10 a.m. Welcome Beth McCarville, MD
Adina L. Alazraki, MD, FAAP
   Hepatoblastoma: Diagnosis and Staging  
8:10 - 8:30 a.m. Imaging Challenges: CT vs. MR and Use of Hepatocyte Specific Contrast Agents Alexander J. Towbin, MD
8:30 - 8:50 a.m. PRETEXT/POSTTEXT: A Review and Update Beth McCarville, MD
8:50 - 9:10 a.m. A Surgeon's Perspective of PRETEXT System for Hepatoblastoma Max R. Langham, Jr. MD,
9:10 - 9:30 a.m. Rare Liver Tumors of Childhood: Embryonal Sarcoma, HCC and Others Govind Chavhan, MD, DNB,
9:30 - 9:50 a.m. Contrast Enhanced Ultrasound of Liver Masses in Children Judy H. Squires, MD
9:50 - 10:00 a.m. Questions and Answers  
10:00 - 10:15 a.m. Break  

Thyroid Cancer - SAM Session
Moderator: Adina L. Alazraki, MD, FAAP

10:15 - 10:30 a.m. Ultrasound Features of Thyroid Nodules: Distinguishing Benign from Malignant Adina L. Alazraki, MD, FAAP
10:30 - 10:45 a.m. Biopsy of Thyroid Nodules: When and How Adina L. Alazraki, MD, FAAP
10:45 - 11:00 a.m. Radioactive Iodine Therapy vs. Surgical Treatment of Thyroid Carcinoma Marguerite T. Parisi, MD, MS
11:00 - 11:15 a.m. A Clinician's Perspective on Management of Thyroid Nodules Wassim Chemaitilly, MD
11:15 - 11:25 a.m. Questions and Answers  
11:25 -12:15 p.m. Lunch  
12:15 - 1:15 p.m. Tour of St. Jude Children's Research Hospital  

Lymphoma - SAM Session

Moderator: Kathleen M. McCarten, MD

  Hodgkin Lymphoma:  
1:20 - 1:35 p.m. Anatomic Imaging of Hodgkin Disease Kathleen M. McCarten, MD
1:35 - 1:50 p.m. Metabolic Imaging of Hodgkin Disease Steve Y. Cho, MD
1:50 - 2:05 p.m. Surveillance Imaging in Pediatric Lymphoma Anatomic vs. Functional/Metabolic Imaging: Which is Best for Which Tumors? Stephan D. Voss, MD, PhD

  Non-Hodgkin Lymphoma:  
2:05 - 2:20 p.m. Distinguishing Hodgkin from non-Hodgkin Lymphoma on Imaging Helen R. Nadel, MD, FRCPC
2:20 - 2:35 p.m. The Role of PET in non-Hodgkin Lymphoma Barry L. Shulkin, MD, MBA
2:35 - 2:50 p.m. A Clinician's Perspective; Challenges in Standardizing Lymphoma Response Assessment John T. Sandlund, MD
 2:50 - 3:00 p.m. Questions and Answers  
3:00 - 3:15 p.m. Break  

Bone and Soft Tissue - SAM Session
Moderator: Beth McCarville, MD

  Bone Tumors: Diagnosis and Staging  
3:15 - 3:30 p.m. Differential Diagnosis of Bone Tumors: Imaging and Clinical Features and Staging of  Osteosarcoma vs. Ewing Sarcoma Kiery Braithwaite, MD
3:30 - 3:45 p.m. Bone Tumors: Benign Lesions That Mimic Malignancy

Micheál Breen MBBChBAO, (Hons) BMedSc, MRCPI, FFRRCSI, DABR

  Soft-Tissue Tumors - Rhabdomyosarcoma  
3:45 - 4:00 p.m. Clinical and Imaging Features of Rhabdomyosarcoma Kieran McHugh, FRCR
4:00 - 4:15 p.m. A Clinician's Perspective: Challenges in Assessing RMS Response to Therapy and Predicting Outcome Alberto Pappo, MD
  Soft-Tissue Tumors - Non-rhabdomyosarcoma  
4:15 - 4:30 p.m. Overview of the Clinical and Imaging Features of the Most Common Non-rhabdomyosarcomatous Soft Tissue Tumors Simon C. Kao, MD, FACR
4:30 - 4:40 p.m. Questions and Answers  

Interactive Cases - Part 1  
4:40 - 4:55 p.m.   Erika Pace, MD
4:55 - 5:10 p.m.   Sireesha Yedururi, MBBS
5:10 p.m. Adjourn  
5:15 p.m. - 6:30 p.m. Light Reception Marlo Thomas Atrium


View Presentations

Available PDF's of the presentations can be accessed using the online file sharing system, Box. A Box account is NOT required to access the files, but, if you have a Box account or wish to open one, you may do so upon accessing the folder.

Having trouble viewing the presentations?
You may also click here to view.

CE Information

Target Audience

The target audience for this program includes pediatric radiologists, fellows, residents and technologists who perform and report pediatric oncologic imaging. 

Learning Objectives: 

  1. To review recommended imaging approaches for diagnosis, staging and followup of pediatric malignancies.
  2. To discuss emerging and cutting edge imaging technologies in pediatric oncology including functional/metabolic modalities, radiomics and radiogenomics. 
  3. Provide a clinicians perspective on the role of imaging in the management of pediatric malignancies, including cancer predisposition syndromes.

At the completion of this course, participants will be able to understand the current role of imaging in pediatric oncology. Participants will also better understand the clinical perspective of oncologic imaging.

CE Accreditation Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Radiology and the Society for Pediatric Radiology. The American College of Radiology is accredited by the ACCME to provide continuing medical education for physicians. 

The American College of Radiology designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The American College of Radiology is approved by the American Registry of Radiologic Technologists (ARRT) as a Recognized Continuing Education Evaluation Mechanism (RCEEM) to sponsor and/or review Continuing Medical Educational programs for Radiologic Technologists and Radiation Therapists. 

The American College of Radiology designates this educational activity as meeting the criteria for up to 18 Category A credit hours of the ARRT.

Disclosure Information

 Click (here) to view disclosure information.

SAM Credits

Qualified on September 12, 2018 select sessions from this activity meet the American Board of Radiology criteria for a self-assessment (SAM) activity and is designated for up to 12.25 SAM credits toward the ABR Maintenance of Certification Program.